Addition of docetaxel to the cyclophosphamide/thiotepa/carboplatin regimen for autologous stem cell transplantation: A dose-escalation study of docetaxel for breast cancer.

被引：0
|
作者：
Kato, K [1 ]
Ohno, Y [1 ]
Miyoshi, T [1 ]
Mitsuyama, S [1 ]
Ohkubo, H [1 ]
机构：
[1] Kitakyushu Municipal Med Ctr, Fukuoka, Japan
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4579
引用
收藏
页码：367B / 367B
页数：1
相关论文
共 50 条
  • [41] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Falzetti, Franca
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 12 (03) : 165 - 171
  • [42] Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer
    Schrama, JG
    Baars, JW
    Holtkamp, MJ
    Schornagel, JH
    Beijnen, JH
    Rodenhuis, S
    BONE MARROW TRANSPLANTATION, 2001, 28 (02) : 173 - 180
  • [43] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [44] Dose escalation study of pivanex (a histone deacetylase inhibitor) in combination with docetaxel for advanced non-small cell lung cancer.
    Reid, T
    Weeks, A
    Vakil, M
    Cosgriff, T
    Harper, T
    Valone, F
    Magnuson, D
    Bhatnagar, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 685S - 685S
  • [45] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    Awada, A.
    Albanell, J.
    Canney, P. A.
    Dirix, L. Y.
    Gil, T.
    Cardoso, F.
    Gascon, P.
    Piccart, M. J.
    Baselga, J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1500 - 1507
  • [46] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    A Awada
    J Albanell
    P A Canney
    L Y Dirix
    T Gil
    F Cardoso
    P Gascon
    M J Piccart
    J Baselga
    British Journal of Cancer, 2008, 98 : 1500 - 1507
  • [47] A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
    T Demirer
    O lhan
    NM Mandel
    M Arat
    N Günel
    H Çelebi
    C Üstün
    H Akan
    S Demirer
    S Aydıntuğ
    A Uysal
    H Koç
    Bone Marrow Transplantation, 2000, 25 : 697 - 703
  • [48] Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer
    JG Schrama
    JW Baars
    MJ Holtkamp
    JH Schornagel
    JH Beijnen
    S Rodenhuis
    Bone Marrow Transplantation, 2001, 28 : 173 - 180
  • [49] A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
    Demirer, T
    Ilhan, O
    Mandel, NM
    Arat, M
    Günel, N
    Çelebi, H
    Üstün, C
    Akan, H
    Demirer, S
    Aydintug, S
    Uysal, A
    Koc, H
    BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 697 - 703
  • [50] Thiotepa-cyclophosphamide high-dose immunosuppression with autologous stem cell transplantation in refractory or relapsed multiple sclerosis
    Roccia, T.
    Ciceri, F.
    Bernardi, M.
    Peccatori, J.
    Corti, C.
    Greco, R.
    Radaelli, M.
    Moiola, L.
    Martino, G.
    Comi, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S137 - S137
12345